Top

Tag: biotechnology


News

27 drugmakers to provide generic COVID drug to low-income countries

January 21, 2022

Via: Pharmaphorum

In October, the Geneva-based Medicines Patent Pool, a United Nations-backed public health group announced a voluntary licensing agreement by which Merck would license the drug to companies that meet certain quality-assurance specifications. Neither Merck nor its development partners will receive […]


Industry, Vaccines

COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they’re a double-edged sword for J&J and AZ

January 20, 2022

Via: FiercePharma

Pfizer and Moderna are now two of the leading pharma companies in the U.S. when it comes to public image, thanks to their COVID vaccines. On the flip side, vaccine rivals J&J and AstraZeneca have seen their reputations plummet. This […]


Cell and Gene Therapy, Industry

New Gene Therapy May Potentially Treat Severe Form of Epilepsy

January 20, 2022

Via: Genetic Engineering and Biotechnology News

Scientists from the University of Virginia (UVA) School of Medicine describe in a study involving mouse models how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the […]


Cell and Gene Therapy, Industry

CBM and Penn Strike $100M Cell & Gene Therapy Deal

January 20, 2022

Via: Contract Pharma

The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania’s Gene Therapy Program (GTP) have signed a landmark collaboration agreement, to combine Penn’s knowledge and expertise in the development of Gene therapies with CBM’s manufacturing capacity and singular focus […]


News

Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech

January 19, 2022

Via: FiercePharma

64x Bio, a fledgling synthetic cell and gene therapy manufacturer, brought in $55 million in a series A round of fundraising. The company, which has about 10 employees and was founded in 2020 out of the Harvard Department of Genetics, […]


FDA, Regulations

FDA Agrees to Use of New Manufacturing Process for Nomacopan in Clinical Studies

January 19, 2022

Via: Contract Pharma

Akari Therapeutics, Plc, a late-stage biopharmaceutical company focused on therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, has announced that the U.S. Food and Drug Administration ( FDA ) has agreed, […]


Industry, Vaccines

mRNA COVID-19 vaccines safe for pregnant women, finds EMA review

January 19, 2022

Via: European Pharmaceutical Review

According to the European Medicines Agency (EMA)’s COVID-19 task force (ETF), a growing body of evidence suggests that messenger RNA (mRNA) COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies. The ETF undertook a detailed review […]


Industry, Vaccines

WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased

January 19, 2022

Via: Drugs.com

If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday. However, if wealthier countries don’t share their resources with poorer countries, there will continue to be high […]


Manufacturing, Research and Development

Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech

January 18, 2022

Via: FiercePharma

Ori Biotech, which is on the cusp of launching an innovative process for manufacturing cell and gene therapies (CGTs), tallied more than $100 million in its latest funding round. The company will use the money to add key personnel in […]


Manufacturing, Research and Development

Stanford spinout forms drug delivery joint venture with Chinese biotech

January 18, 2022

Via: FiercePharma

Stanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of […]


Biotech, Industry

How CRO venture capital relationships can help biotech fundraising

January 18, 2022

Via: Biopharma Dive

Developing drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]


Manufacturing, Research and Development

Samsung Biologics to Construct New Manufacturing Facility for Next-Gen Vaccines and CGT

January 18, 2022

Via: Biopharm International

Samsung Biologics announced on Jan. 12, 2022 that it plans to start building a new facility (designated Plant 5) at Songdo in Incheon, South Korea, this year. The facility will offer manufacturing for multi-modal products, including cell and gene therapies […]